Caregen is a dynamic, progressive and R&D
based skin biology company.
R&D is the heart of fulfilling Caregen's purpose and our expertise in small molecule synthesis of biomimetic peptides truly capture the essence of our company.
We share a clear vision “To be a global leading company of growth factors and biomimetic peptides for cosmeceuticals and pharmaceuticals.”
A firm commitment to technology and innovation in all its operating divisions has given Caregen the competitive advantage to be the provider of choice for active ingredients and innovative products for cosmeceutical industry.
Over the years, Caregen has grown to encompass not only Cosmeceutical but also expanding R&D to pharmaceutical,
relating to skin disease such as Atopic Dermatitis, Psoriasis, periodontal disease, rheumatoid arthritis etc.
Through the combined efforts of our employees, I am confident that companies around the world will continue to turn to Caregen to benefiting their business through Science and Technology.
CAREGEN CEO & CTO Yongji Chung